Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 18(12): e0294075, 2023.
Article in English | MEDLINE | ID: mdl-38096242

ABSTRACT

BACKGROUND: Obesity is a global health concern and risk factor for cardiovascular disease. The assessment of central blood pressure (cBP) has been shown to improve prediction of cardiovascular events. However, few studies have investigated the impact of obesity on cBP in adults, and invasive data on this issue are lacking. This study aimed to evaluate cBP differences between patients with and without obesity, identify cBP determinants, and evaluate the accuracy of the algorithm Antares for non-invasive cBP estimation. METHODS: A total of 190 patients (25% female; 39% with BMI ≥30kg/m2; age: 67±12 years) undergoing elective cardiac catheterization were included. cBP was measured invasively and simultaneously estimated non-invasively using the custo screen 400 device with integrated Antares algorithm. RESULTS: No significant cBP differences were found between obese and non-obese patients. However, females, especially those with obesity, had higher systolic cBP compared to males (P<0.05). Multiple regression analysis showed that brachial mean arterial pressure, pulse pressure, BMI, and heart rate predicted cBP significantly (adjusted R2 = 0.82, P<0.001). Estimated cBP correlated strongly with invasive cBP for systolic, mean arterial, and diastolic cBP (r = 0.74-0.93, P<0.001) and demonstrated excellent accuracy (mean difference <5 and SD <8 mmHg). CONCLUSIONS: This study discovered no significant difference in cBP between obese and non-obese patients. However, it revealed higher cBP values in women, especially those with obesity, which requires further investigation. Additionally, the study highlights Antares' effectiveness in non-invasively determining cBP in obese individuals. This could improve the diagnosis and treatment of hypertension in this special patient population.


Subject(s)
Blood Pressure Determination , Hypertension , Male , Adult , Humans , Female , Middle Aged , Aged , Blood Pressure/physiology , Obesity/complications , Obesity/diagnosis , Diagnostic Techniques, Cardiovascular
2.
Article in English | MEDLINE | ID: mdl-36707104

ABSTRACT

INTRODUCTION: Antares is a pulse wave analysis (PWA) algorithm designed to allow a non-invasive estimation of central (aortic) blood pressure (cBP) using automated oscillometric blood pressure (BP) devices. Diabetes may affect elastic and muscular arteries differently, resulting in disparate pulse wave characteristics in central and peripheral arteries, which may limit the accuracy of PWA devices. The aim of our study was to evaluate the accuracy of Antares for estimating cBP as compared with invasively measured cBP in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: In this study, consecutive patients undergoing elective coronary angiography were recruited between November 2017 and September 2020. In 119 patients with type 2 diabetes, cBP was measured invasively and simultaneously determined non-invasively using the custo screen 400 device with the integrated Antares algorithm. RESULTS: The mean difference between the estimated and invasively measured cBP was 1.2±6.3 mmHg for central systolic BP (cSBP), 1.0±4.3 mmHg for central mean arterial pressure (cMAP) and 3.6±5.7 mmHg for central diastolic BP (cDBP). High correlations were found between estimated cBP and invasively measured cBP (cSBP: r=0.916; cMAP: r=0.882; cDBP: r=0.791; all p<0.001). CONCLUSIONS: The present study suggests that the Antares algorithm incorporated into the custo screen 400 device can estimate cBP with high accuracy turning a conventional oscillometric BP device into a type II device for the non-invasive estimation of cBP, which is applicable in patients with type 2 diabetes. Integration of Antares into commercially available BP devices could facilitate the introduction of cBP into routine clinical practice as a part of disease and risk management.


Subject(s)
Arm , Diabetes Mellitus, Type 2 , Humans , Blood Pressure/physiology , Blood Pressure Determination/methods , Diabetes Mellitus, Type 2/diagnosis , Pulse Wave Analysis
3.
Int J Artif Organs ; 42(9): 525-527, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31104536

ABSTRACT

The use of the Impella left ventricular assist device is feasible in severe cardiogenic shock. Ischemic complications due to the arterial cannulation may occur. The following case shows how the use of a perfusion adapter for antegrade leg perfusion treats ischemia of the lower extremities.


Subject(s)
Extracorporeal Membrane Oxygenation/methods , Heart-Assist Devices , Ischemia/therapy , Lower Extremity/blood supply , Female , Humans , Ischemia/etiology , Middle Aged , Peripheral Arterial Disease/complications , Shock, Cardiogenic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...